The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation

The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation

Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC), but it remains obscure whether EBV is a viral cause of, or only an accompaniment of, NPC. We will discuss the accumulated evidence pointing to the relationship between EBV infection and NPC initiation from epidemiologic, pat...

Full description

Bibliographic Details
Main Authors:	Ai-Di Gu, Mu-Sheng Zeng, Chao-Nan Qian
Format:	Article
Language:	English
Published:	MDPI AG 2012-10-01
Series:	International Journal of Molecular Sciences
Subjects:	Epstein-Barr virus nasopharyngeal carcinoma tumorigenesis infection
Online Access:	http://www.mdpi.com/1422-0067/13/10/13737

Similar Items

Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
by: Zhang Hui, et al.
Published: (2017-06-01)

Wild-type IDH2 contributes to Epstein–Barr virus-dependent metabolic alterations and tumorigenesis
by: Feng Shi, et al.
Published: (2020-06-01)

Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review)
by: D. A. Miroshnichenko, et al.
Published: (2020-11-01)

Immunological response of patients with nasopharyngeal carcinoma against Epstein-Barr virus-specific antigens.
Published: (2004)

Characterization of aberrantly expressed microRNAs in Epstein-Barr virus-associated nasopharyngeal carcinoma.
Published: (2013)

Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
by: Chin King Looi, et al.
Published: (2021-04-01)

Link of Nasopharyngeal Carcinoma and Epstein-Barr Virus
by: Sugiyanto Sugiyanto, et al.
Published: (2018-10-01)

Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana
by: Richmond Ayee, et al.
Published: (2020-07-01)

Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein–Barr Virus Infection
by: Xintong Peng, et al.
Published: (2021-08-01)

Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein‐Barr Virus: An analysis of a prospective study in southern China
by: Ting Hu, et al.
Published: (2019-05-01)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
by: Pok Man Hau, et al.
Published: (2020-05-01)

Prevalence of Epstein Barr Virus in biopsy specimens of nasopharyngeal carcinoma from Serbian patients
by: Banko Ana, et al.
Published: (2014-01-01)

Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells
by: Chung-Chun Wu, et al.
Published: (2018-04-01)

Analysis of Serum Levels of IgA Antibodies to Epstein Barr Virus Capsid Antigens in the Spouses and the Children of Patients with Nasopharyngeal Carcinoma
by: Jiru CHENG, et al.
Published: (2009-08-01)

Circulating cell‐free epstein–barr virus DNA levels and clinical features in Moroccan patients with nasopharyngeal carcinoma
by: Amina Gihbid, et al.
Published: (2021-02-01)

Epstein–Barr Virus Infection of Pseudostratified Nasopharyngeal Epithelium Disrupts Epithelial Integrity
by: Fenggang Yu, et al.
Published: (2020-09-01)

Expression of Epstein-Barr virus proteins and their detection by IgG antibodies
by: Rosek, Alyssa
Published: (2018)

Associations between environmental factors and serological Epstein‐Barr virus antibodies in patients with nasopharyngeal carcinoma in South China
by: Ting Zhou, et al.
Published: (2019-08-01)

Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma
by: Rob J. A. Verhoeven, et al.
Published: (2019-10-01)

Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma
by: Jian Zhang, et al.
Published: (2018-12-01)

Epstein-Barr Virus-Encoded Products Promote Circulating Tumor Cell Generation: A Novel Mechanism of Nasopharyngeal Carcinoma Metastasis
by: Yang Z, et al.
Published: (2020-01-01)

DNA Epstein-Barr virus (EBV) sebagai biomaker diagnosis karsinoma nasofaring
by: Janti Sudiono, et al.
Published: (2013-09-01)

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level
by: Sai-Lan Liu, et al.
Published: (2020-02-01)

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort
by: Xue‐Song Sun, et al.
Published: (2019-08-01)

Meta-analysis: Epstein-Barr Virus genes - EBNAs, LMPs, and EBERs one of the major causes of nasopharyngeal cancer
by: Nguyễn Hoàng Anh Tuấn, et al.
Published: (2019-09-01)

Detecção de Epstein-Barr vírus no carcinoma da nasofaringe: implicações numa área de baixo risco Epstein-Barr virus detection in nasopharyngeal carcinoma: implications in a low-risk area
by: Eduardo Breda, et al.
Published: (2010-06-01)

Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: Study design, methods and feasibility
by: Guo Xiu, et al.
Published: (2006-06-01)

Nasopharyngeal carcinoma with pericardial metastasis
by: Shang-Wen Chen, et al.
Published: (2011-07-01)

Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas
by: Wang Xinying, et al.
Published: (2012-02-01)

Epstein-Barr Virus Infection Alters Cellular Signal Cascades in Human Nasopharyngeal Epithelial Cells
by: Angela Kwok Fung Lo, et al.
Published: (2006-03-01)

CD47 Overexpression Is Associated with Epstein–Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma
by: Wang ZH, et al.
Published: (2020-04-01)

Bioinformatics analyses of high-throughput genomic and transcriptomic data from nasopharyngeal carcinoma cell line, xenografts and associated Epstein-Barr virus
Published: (2014)

Whole-Tumor Histogram and Texture Imaging Features on Magnetic Resonance Imaging Combined With Epstein-Barr Virus Status to Predict Disease Progression in Patients With Nasopharyngeal Carcinoma
by: Qiao Li, et al.
Published: (2021-03-01)

Long noncoding RNAs involvement in Epstein-Barr virus infection and tumorigenesis
by: Jing Zhang, et al.
Published: (2020-04-01)

Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma
by: Lisheng Zhu, et al.
Published: (2021-09-01)

Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
by: Yongqiao He, et al.
Published: (2021-08-01)

Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein‐Barr virus associated nasopharyngeal carcinoma
by: Lingzhi Liu, et al.
Published: (2019-06-01)

Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma
by: Rong Tan, et al.
Published: (2020-11-01)

Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma
by: Guo, Q., et al.
Published: (2022)

Progesterone analogues reduce plasma Epstein–Barr virus DNA load and improve pain control in recurrent/metastatic nasopharyngeal carcinoma patients under supportive care
by: Chia-Yen Hung, et al.
Published: (2017-08-01)